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CHAPTER]
INTRODUCTION
Heme proteins are arguably the most versatile class of proteins in biology. Their
wide ranges of functions and spectroscopic characteristics have largely been attributed to
the structural components of the protein environment that constitute the heme active site.
Although many structural variables are influential, specifically, the identiti s of the
proximal ligand and distal ligand residues make up the major structural determinants of
heme protein functional properties.
Four of the six heme iron coordinate positions are occupied by protoporphyrin IX
pyrrole nitrogens with one or both of the two remaining coordinate po itions occupied by
residues contributed by the protein. Typically, heme proteins are classified on the basis
of the heme-iron center coordination number. Six-coordinate electron-transfer proteins
include bis-hisdidine-ligated b-type cytochromes and the methionine-histidine
coordination of c-type cytochromes. Like the cytochromes, other heme proteins utilize
His as the proximal ligand to a five-coordinate heme-iron, rather than the six-coordinate
heme-iron characteristic of electron-transfer hemeproteins. These five-coordinate species
include the oxygen storage and transport proteins (myoglobin, Mb, and hemoglobin), a
majority of peroxidases, and heme oxygenases. Catalases employ a Tyr phenolate ligand,
while a number if interesting heme proteins possess a Cys thiolate ligand, i.e. nitric oxide
synthase (NOS), chloroperoxidase, the carbon monoxide sensing protein, CooA, and the
large family of cytochrome P-4S0 which is a monooxygenase.
Of particular interest in this work is the heme protein cytochrome b5 obtained
from the outer mitochondrial of the rat hepatocyte (OM cyt b5) [I]. OM cyt bs is an
electron-transfer protein in which the heme active site is shuttled between different
oxidation states in order to accept or donate electrons and is suggested that it might be a
physiological redox partner of cytochrome c.
The axial ligand histidines (His39 and His63) of OM cyt b5 have been amenable
to manipulation by site-directed mutagenesis, thus providing a protein that can be over-
expressed in E. coli and purified [2, 3]. Therefore, it is reasonable to presume that
mutating the axial histidine(s) for a cysteine can result in a species that will lend itself to
study.
For this work, OM cyt b5 was mutated to model the heme coordination (cysteine)
found in the ubiquitous family of cytochromes of P-450. As stated above, P-450 is a
heme-containing monooxygenase. The enzyme activates molecular oxygen by utilizing
two electrons and inserts one oxygen (oxygenation) to various organic substrates.
Biological activities and unique spectroscopic features of P-450 are attributed to unu ual
cysteine ligation to the heme. The literature of cytochrome P-450 is so vast, and so many
people have made important contributions, that it would be impossible to give even a
representative set of references. In that respect, an excellent review by Dawson and Sono
[4] provides links to numerous original papers and for a comprehensive review of all
aspects ofP-450 see Cytochrome P-450: Structure, Mechanism, and BiochemisJfY, editor
P.R. Ortiz de Montellano [5].
Monooxygenase activity is one fu.nction of a thiolate-coordinated heme protein
system. Other thiolate-ligated heme proteins include chloroperoxidase, which is able to
-chlorinate substrates, nitric oxide synthase, and a gas-sensing enzyme CooA. The
question of how the same thiolate-heme center performs different function in variou
protein systems is extremely important, yet remains largely unanswered. Mutation of a
heme protein to introduce thiolate axial ligation to a protein which does not naturally
possess this coordination (OM cyt b-) could offer insight into this important que tion by
studying the structure and spectroscopic properties following the appropriate mutant
prokin.
Site-directed mutagenesis has enabled this lab to engineer a mutant OM cyt bs
heme protein as a structural mimic for a different heme protein. This technique allows
alteration of axial ligation of OM cyt bs (bis-histidine) in order to test principles obtained
fonn earlier studies of the native enzyme that the mutated OM cyt bs is mimicking to
detennine key structural features governing the variability among heme protein functions.
The first mutant constructed and characterized is H39C where the native axial
ligand His39 was mutated for a Cys. The second mutant engineered and examined is
H63C in which the other axial ligand His63 was replaced for a Cys. The third mutant of
OM cyt bs prepared and characterized is a double mutant in which both axial histidines
were replaced for Cys. In this mutant variant, native His39 was mutated for Val and
His63 mutated for Cys (H39V/H63C).
The site-directed mutagenesis, axial ligand replacement strategy, has been
successfully employed in the myoglobin (Mb) system with the H93C mutant, which
compared favorably spectroscopically with cytochrome P-450CAM in the exogenous
ligand-free ferric state [6-8]. Mb differs in axial heme ligation to OM cyt bs in that Mb
has a histidine as a coordinated proximal ligand and a histidine in the distal heme pocket
3
•that does not coordinate; hence the distal site in Mb is available for exogenous ligand
such as O2 or CO. OM cyt b5, like other electron-transport proteins, is coordinated by
two histidines, and in general, these proteins do not bind oxygen. Because of this, OM
cyt b5 may not be the best choice to model five-coordinate thiolate-ligated proteins that
have a distal site capable of binding oxygen.
However, both P-4S0 and chloroperoxidase typically are converted into an
inactive six-coordinate enzyme that cannot bind O2 (P-420 and C-420, respectively).
These inactive forms have been characterized and it is believed that the inactivity is
largely due to the stmcture and coordination of the heme active site which to date is not
known for certain [9, 10]. Mutating only one of the axial histidines for a cysteine in OM
cyt b5, (the H39C and H63C variants) may shed some light on the structural relationships
that lead to inactivity of P-4S0 and chloroperoxidase. Likewise, the double mutant of
OM cyt b5 (H39V/H63C) could provide a model for the coordination found in P-450.
Another reason to choose to mutate OM cyt b5 to model thiolate-Iigated heme
proteins is the failure of the Mb mutants to successfully model P-4S0 in the ferrous and
ferrous carbonmonoxy oxidation states. The contributions that are provided by the
protein moiety to the characteristics of these ferrous forms could be further ascertained
with the double mutant H39VIH63C. FUl1hermore, recent studie invoJ ving cytochrome
c peroxidase [I J] and heme oxygenase [12] in which both were mutated to achieve
thiolate ligation have also failed to achieve thiolate-Fe coordination upon reduction of the
Iron.
fn this work, spectroscopic characteristics describing each of the three OM cyt h5
mutants (H39C, H63C, and H39V/H63C) have been obtained. The results of these
4
Linvestigations point to oxidation of the cysteine to cysteinsulfinic acid and further
oxidation to cysteic acid in the ab ence of oxidants other than air. This is a unique
characteristic of these mutants. To date, the explanation given for the failure of thiolate-
Fe ligation in the ferrous forms of the Mb mutants and the inactivity of ferric P-420 and
C-420 has been protonation of the thiolate or elongation of the Fe-thiolate bond [6, 9, 10].
fhe work presented here provides an alternate explanation with evidence of oxidation of
the cysteine.
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CHAPTER II
EXPERIMENTAL
Site-directed Mutagenesis
Purpose of Mutagenesis. Mutagenesis offers a convenient avenue to incorporat
base changes in genes that ultimately lead to the desired amino acid substitution in the
protein that the gene is coding for. In this work, three separate mutants involving four
amino acid substitutions were constructed. In the first mutant, a histidine at position 39
was substitutes for a cysteine (H39C). The second mutant substitutes the histidine at
position 63 for a cysteine (H63C). The final mutant involved two amino acid changes; a
valine for the histidine at position 39 and a cysteine for the histidine at position 63
(H39VIH63C). The following will provide experimental details for the mutagenesis
process as well as details for primer design.
Primer design. The transformer site-directed mutagenesis kit (Clontech) and the
recombinant plasmid MRL 1 [1] were used to construct all mutants. The sequences
corresponding to the mutagenic primer designed to introduce mutations H39C, J l63C,
H39V, and the sequence corresponding to the selection primer (AflllI to B1?IlI) arc
5'-CCCGTTTCCTGTCTGA-ATGCCCGGGCGGCGAAGAAGGTTCTGC-3',
5'-CTTTCGAAGATGTTGGCTGC-TCTCCGGATGCGCGTG-3',
5'-CCCGTTTCCTGTCTGAAGTTCCGGGCGGCGA-AGAAGGTTCTGC-3', and
5' -GGGGATAACGCAGGAAAGAAGATCTGAGCAAA-AGGCC-3', respectively.
The underlined codons represent mismatches introduced to generate the mutations. The
H39C and H63C mutants were constructed with the corresponding mutagenic and
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Figure II-I. Map of plasmid MRLI [I] showing the relative positions of the genes and
enzyme restriction sites. The unique restriction site AflIlI is shown to be over 200 bp
upstream from the gene. The gene for OM cyt bs is located within the multiple cloning
site (MCS). The EcoRI and BamHI restriction sites are the insertion points, thus OM 17 5
also contains these sites (See Figure 2). The expanded polylinker region illustrates that
the T3 promoter is located on the inner strand of the plasmid, as a result this is the strand
that the primer will anneal to in order to initiate the mutations within the OM bs gene.
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selection pnmer, and the double mutant H63CfH39V was constructed with the two
mutagenic and selection primers used simultaneously.
For the following discussion on primer design, refer to the circular map of the
plasmid MRL 1 and the amino acid sequence of the OM cyt b5 gene (Figure 1 and 2,
respectively). Several factors playa role in the design of the primers. The function of
the selection primer is to replace the original unique restriction site with another unique
restriction site; in this case, AflIII to BgllI. It is desirable that the unique restriction site
not be located in a position that interferes with the expression of the target gene. As
shown in Figure 1, the unique restriction site is over 200 bp upstream from the gene OM
cyt b5. The primers used to introduce mismatches in the target gene OM cyt b5 were
designed and constructed for optimum annealing. The length of the primer contain at
least ten nucleotides of uninterrupted matched sequences flanking each side of the
mismatch codon. In addition, it is important that the GC content of the primer be greater
than 50%. The rich GC content increases annealing stability, as nucleotides G and '
form three hydrogen bonds between them upon forming a ba e pair in the double helix,
whereas an AT base pair forms only two hydrogen bonds. Another factor for primer
design is the choice of codons used. Since most amino acids can be coded by two to six
codons [2], then theoretically any codon used in the primer that codes for that amino acid
should introduce the desired mutation. However, according to Ikemura [4], E. coli
clearly exhibits a preference in its codon usage. Therefore, the choice of codon used in
the primer to introduce the mutation is based on preferences that E. coli exhibits for one
codon over another.
9
-Eco RI
5' GGG~MTICCAT ATG GAT GGC CAG GGC TCT GAT CCG GCG GTT
Met Asp Gly Gin Gly Ser Asp Pro Ala Val
3' CCCCTIMGGTA TAC CTA CCG GTC CCG AGA CTA GGC CGC CM
ACC TAC TAC CGT CTG GM GM GTI GCG AM CGT MC ACC
Thr Tyr Tyr Arg Leu Glu Glu Val Ala Lys Arg Asn Thr
TGG ATG ATG GCA GAC CTI cn CM CGC Tn GCA nG TGG
GCG GM GM ACC TGG ATG GTT ATC CAT GGC CGT GTT TAC
Ala Glu Glu Thr Trp Met Val lie His Gly Arg Val Tyr
CGC cn cn TGG ACC TAC CM TAG GTA CCG GCA CM ATG
His39
GAT ATC ACC CGT nc CTG TCT GM CAC CCG GGC GGC GM
Asp lie Thr Arg Phe Leu Ser Glu His Pro Gly Gly Glu
CTA TAG TGG GCA MG GAC AGA CTT GTG GGC CCG CCG CTT
GM GTT CTG CTG GM CAG GCG GGC GCG GAT GCG ACC GM
Glu Val Leu Leu Glu Gin Ala Gly Ala Asp Ala Thr Glu
cn CM GAC GAC CTT GTC CGC CCG CGC CTA CGC TGG CTT
His63
TCT TTC GM GAT GTT GGC CAC TCT CCG GAT GCG CGT GM
Ser Phe Glu Asp Val Gly His Ser Pro Asp Ala Arg Glu
AGA MG CTT CTA CM CCG GTG AGA GGC CTA CGC GCA CTT
ATG CTG AM CAG TAC TAC ATC GGC GAT GTT CAC CCG MC
Met Leu Lys Gin Tyr Tyr lie Gly Asp Val His Pro Asn
TAC GAC TTT GTC ATG ATG TAG CCG CTA CM GTG GGC TTG
~BDm HI
GAT CTG AM CCG MA TMTAA GATCCGGG 3'
Asp Leu Lys Pro Lys
CTA GAC TTT GGC TIT ATTATTCCTAGGCCC 5'
Figure 11-2. DNA and amino acid sequence of OM cyt bs. The heme axial ligands that
were mutated are outlined. The gene is inserted in MRL 1 at the enzyme restriction sites
Bam HI and Eco RI, thus the bottom strand of the linearized gene corresponds to the
inner strand of MRL 1 (See Figure 1).
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Another main factor in the design of the mutagenic primer involves the strand of
the plasmid MRL 1 to which the primer will anneal. The mutagenic and selection primers
must anneal to the same strand of the plasmid. Figure 1 shows a map of the plasmid
MRL I including the expanded polylinker region showing the restriction sites EcoRl and
BamHI that serve as insertion points for the gene that codes for the OM cyt bs protein.
Figure 2 is the DNA and an1ino acid sequence of the OM cyt bs gene. In the recombinant
plasmid MRLI, the T3 RNA polymerase promoter will initiate transcription, therefore,
when the plasmid is denatured (or strands separated), the selection and mutagenic primers
will anneal to the inner strand. Consequently, the sequence of the selection primer must
be the complement of the inner strand. For clarity, the bottom strand of the gene in
Figure 2 corresponds to the inner strand of the plasmid, therefore the sequence of the
mutagenic primer must be the complement of the bottom strand, or simply the sequence
of the top strand (Figure 2). The Core Facility at OSU synthesized the selection and
mutagenic primers. For a complete discussion 011 the design of th recombinant plasmid
MRLl, see Rivera et al.[1].
Mutagenesis reactions. For the following discussion on site-directed
mutagenesis, please refer to Figure 3, which us adapted from the Clontech technical
bulletin PR473 75 [3]. In step one, the double-stranded plasmid MRL I is denatured and
the phosphorylated primers are annealed by incubating the mixture at 100°C for 3 min.
After this point, the reaction mixture is to be kept on ice at all times unless indicated. To
synthesize the second strand, the reaction mixture is incubated with T4 DNA polymerase
and T4 DNA ligase at 37°C for two hours, then at 70 °C for five minutes to stop the
reaction. The T4 DNA polymerase is used to synthesize the second strand and T4 DNA
II
..
ligase is used to till the gaps. tep three is the first digestion with 15 units of selection
enzyme ~flIII. This digestion effectively linearizes DNA that did not incorporate the
mutation at the unique restriction site. The resulting 0 A reaction mixtur
transformed into BMH 71-18 mulS E. coli cells and subsequently isolated from the
overnight culture. At this point, the reaction mixture contains the mutated plasmid and
any remaining parental plasmid that remained uncut in step three and was subsequently
amplified in step four. To rid the DNA mixture of all traces of parental pia mid a final
digestion with 15 units of AjlTII is performed. The final step of mutagenesis are
transformation into the E. coli strain XLI Blue for amplification followed by isolation of
the DNA from an overnight culture of an isolated colony. The mutated OM cyt b5 gene is
then separated from the pBS+ plasmid (MRL 1) by simultaneous digestion with BamHI
and NdeI and then purified with the aid of agarose gel electrophoresis and the GeneClean
II Kit (Bio 10 1). Likewise, the expression vector pET-II a is digested and purified. The
results of the digestions and purifications are a small insert that is made up of the mutated
OM cyt b5 gene and a larger strand of DNA that i the expression vector p T-II a with
sticky ends that now correspond to the 5' and 3' ends of the small insert. A ligation
reaction is then setup where 100 ng of pET-II a fragment is reacted with the small insert
in quantities two, four, and eight times that of the pET-l1a fragment. The enzyme T4
DNA ligase and its corresponding buffer are added and the mixture allowed to react for
14-16 h at 16°C. An additional 0.5 ilL of ligase is added after 12 h. The ligation
reactions are then transformed into the E. coli cell strain XL-l Blue for amplification.
The DNA purified from this transformation is screened for the mutations. Finally, the
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Figure 3. Strategy for site-directed mutagenesis [3].
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-recombinant plasmid pET-II a containing the mutated gene sequence is tran formed into
the E. coLi strain BL21 (DE3) for expression of the protein.
Protein Expression
Lysing of cells. A single colony of E. coli cells BL21 (DE3), containing the
recombinant pET-lla plasmid was grown overnight (37°C) in 5 mL of LB medium
containing ampicillin (l00 mg/L). The overnight culture was u ed to inoculate four I-L
culture flasks of LB medium with the same concentration of ampicillin, and the cells
were grown at 37°C until the 00600 reached a value between 0.8 and 1.0 (approximately
4.5 h). IPTG (isopropyl-~-thjogalactoside)was added to a final concentration of 1.0 mM.
Approximately 10 min after induction of protein synthesis, 17 mg of 8-aminolevulinic
acid and 100 mg of FeS04 • 7H20 were added per liter of cell culture. The cells were
harvested by centrifugation 3.5 h after induction of protein synthesis. The harvested cells
were resuspended in of lysis buffer (2 mUg cells, 50 mM Tris. I mM EDTA and 100
mM NaCL, pH 8.0) and lysed with lysozyme (160 /-tLig cells, 10 mg/mL) in the presence
of PMSF (phenylmethanesulfonyl fluoride, 32 ilLig cells, 50 mM) and deoxycholic acid
(4 mg/g cells) at 4°C for 20 min, stirring every five minutes. The lysate was equilibrated
at 37°C for 20 min and then stirred at room temperature for one hour. 0 ase I was
added and stirred for another hour at room temperature at which time the lysate was no
longer viscous. Cell debris was removed by ultra centrifugation (45,000 RPM at 4 °C for
I h) and the resulting supernatant dialyzed (Spectrapor; 6-8000 MWCO) overnight at 4
°C against ion-exchange buffer (10 mM EDTA and 50 mM Tris, pll 7.8).
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-Ion-Exchange Chromatography. The desalted solution was then loaded onto
an anion-exchange resin (DE52, Whatman) previously equilibrated with ion-exchange
buffer (l0 mM EDTA and 50 mM Tris, pH 7.8) and eluted with a linear salt gradient (0.0
to .50 M NaCL). The chromatographic fractions were followed by monitoring the
absorbance ratio A280 I~20(422). The fractions with purity ratio less than 4 (A28o I~20(422))
were pooled and concentrated by ultrafiltration (Y3 Diaflo ultrafiltration membranes,
Amicon).
Size-exclusion Chromatography. Further purification was achieved by size-
exclusion chromatography with a Sephadex G-50 column (2.6-cm diameter X IOO-cm
length) equilibrated with 100 mM NaCI, 100 mM Tris and 1 mM EDTA, pH 7.0 at 4 0c.
Fractions with purity ratio less than I (A28o/A42o(422)) were pooled and concentrated by
ultrafiltration to approximately 2-5 mL. The final protein solution was exchanged tor
sodium phosphate buffer (50 mM, pH 7 or pH 8).
Special conditions. For the double mutant H63C/H39V, imidazole (1 mM) was
added to all buffers before size-exclusion chromatography. In several purifications or
the H63C variant, dithiothreitol (DTT) was present in all buffers during puri fication at a
final concentration of] mM. These purifications with DTT added were also kept scmi-
anaerobic with a stream of inert gas bubbled in the solutions. Furthermore, the DTT-
containing solutions were kept at 4 0c.
15
Electronic Absorption Spectroscopy
Hewlett-Packard. UV-vis spectra of the variants were collected on a Hewlett-
Packard 8452A diode array spectrophotometer equipped with a jacketed cuvette holder
connected to a thermostated water bath.
Ocean Optics. In several experiments an Ocean Optics S2000 spectrophotometer
with a DT-IOOO deuterium tungsten halogen light source was used. A 400 ~m diameter
bifurcated tiber optic cord assembly was used to carry the light to the cuvette holder and
then into the detector. Acquisition software was set to acquire data at an integration time
of 13 ms, averaging 25 spectra, and a boxcar average of 5.
EPR Spectroscopy
EPR spectra of samples containing the LS and HS forms of the H63C variant in
the presence and in the absence of imidazole (1.0 mM) were acquired using a Bruker
EPR spectrophotometer operating at 9.34 GHz. The samples were analyzed at 4.0 K
under the following conditions: receiver gain, 1.0 x 105; microwave power, 0.200 mW;
modulation frequency, 100 kHz; modulation amplitude, 1.799 G.
Mass Spectrometry
Initially, protein solutions were dialyzed against 50 mM NH4HCO] (pH 8.5) and
subsequently concentrated by ultrafiltration to approximately 1 mL. One hundred
microliters of the resultant solution was diluted with 100 I-lL of 10 mM ammonium
acetate and then injected (5 I-lL/min) into a Sciex API III triple quadrupole mass
spectrometer equipped with an atmospberic pressure ion source. Sampling of the positive
16
-ions was achieved in the first quadrupole using a voltage difference of 125 V. Increments
of 0.1 amu were collected in the range 400-1000 amu.
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CHAPTER III
OM cyt bs H39C
Ferric H39C
Electronic characteristics of H39C. Mutagenesis of the H39C variant of OM
cyt b5 and subsequent over-expression m E. coli was performed as de cribed in
Experimental. The codon, which codes for the histidine residue at position 39, was
replaced by one that codes for cysteine. Seq uencing the mutated gene corroborated the
latter. The protein was then expressed and purified. As a final purification step, the
protein was exchanged for a buffer containing 50 mM NaHP04 (pH 7). The electronic
spectrum of the freshly purified H39C variant exhibits several distinct characteristics.
Figure 1 depicts the electronic absorption spectrum of the oxidized form of the variant
that displays a prominent 8 band at 360 nm, a Soret band at 422 nm, an a band (572 11m),
which is a shoulder to the more intense ~ band (544 nm), and two additional weak
absorption bands at 638 nm and 750 nm. The Soret band of the H39C mutant (422) is
significantly red-shifted from the Soret band ofWT OM cyt b5 (412 nm) (Figure Ib) [1],
indicating that the Cys39 residue has a significant effect on the electronic environment or
the heme iron. The shape of the spectrum indicates that the protein is majority low-spin
(S= 1/2) and thus a hexa-coordinated heme iron. However, due to the appearance of a
charge-transfer band at 638 11m, a minority species exists that appears to be high-spin
(S=5/2), which indicates a five-coordinated high-spin ferric heme iron (see below).
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-Comparison to wild-type Myoglobin. A water and a histidine ligated to the
heme iron would induce a high-spin iron (FeJ+; S=5/2), such as that in wild-type
myoglobin (WT Mb) (Figure 2) [2]. A high-spin iron such as the one found in Mb ha
spectroscopic characteristics that include a sharp Soret band nonnaJly located bet~een
400 and 410 run, no discernable a and ~ peaks in the visible region (500-700 run). and a
high-spin marker at approximately 630 run (Figure 2). In contrast, the electronic
spectrum of the H39C variant of OM cyt b5 exhibits a Soret band at 422 nm and a
prominent ~ peak at 544 nm (Figure I). This shape is more consistent with that of a low-
spin iron (FeJ+; S=II2) as seen in wild type OM cyt b5 (Figure Ib). It is reasonable to
assume that the endogenous ligand in the H39C mutant of OM cyt b5 (His 63) is retained.
The most likely candidate for the second axial ligand is the thiolate of Cys39. or a water
molecule. Since there is a dramatic difference in the shapes of the absorption spectra of
H39C and WT Mb, the thiolate, rather than a water molecule is most likely bound to the
heme iron in a low-spin Fe(llI) heme (S = II2) configuration.
Comparison to other thiolate-ligate<.J proteins. Further evidence of thiolate
ligation to the heme irOll in H39C lies in the weak absorption band in the near IR region
(700-1100 nm) of the spectrum (Figure 1). The thiolate-ligated protein CooA has a weak
absorption band centered at 750 nm. Many researchers have used thi band as a good
diagnostic tool for thiolate ligation [3]. Likewise, the similarities of the H39C pectrul11
to other thiolate-ligated proteins such as P-450cam (low spin) [4], P-420cam [5], and C-420
[6] shows additional evidence ofthiolate ligation to a ferric heme. Cytochromes P-420cam
and C-420 are inactive, six-coordinate. low-spin specIes of P-450cam and
chloroperoxidase, respectively. Table I shows the V spectral data for the ferric species
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-of H39C and the above-mentioned proteins. The enzyme C-420 is of particular intere t
because it is postulated to have a histidine as the sixth ligand to its ferric heme with
Cys29 as the second axial ligand [6]. The shape of the two spectra (H39C and C-420) are
nearly identical, however the Soret peak and ex. shoulder of C-420 appear 5-6 nm red-
shifted. Interestingly, the ferric H39C spectrum more closely resembles P-450cam (low-
spin) and P-420cam, whose heme pocket does not contain a histidine available for ligation.
These similarities suggest that thiolate ligation to a heme iron plays the leading role in
determining the shape of the electronic spectra.
Table III-I. UV-vis spectral data for heme proteins:'
protein 8 (nm) Soret (nm) .p (nm) a (nm) LMCTb (nm) ref.
Fe(III)H39C 360 422 544 570sh 638, 750 c
Fe(IIl)CooA 362 424 540 574sh 649, 750 [3]
Fe(III)P-450cam 356 417 536 569 NRd [4]
Fe(I II )P-420calll 367 422 541 566sh 651 [5]
Fe(1II)C-420 359 424 545 578sh NR [61
bLMCT, ligand-to-metal charge-transferapeak positions are reported in nanometers.
band. cThis work. dNR, not reported.
Imidazole Complex of the H39C mutant of OM cyt bs. Imidazole (1m) is often
used to mimic the amino acid histidine since the side chain of histidine is an imidazole
ring. In addition, 1m is often utilized to probe the accessibility of ligands to the heme and
heme affinity for binding axial ligands [7-9]. 1m (100 mM) was added to a solution of
H39C in phosphate buffer (50 mM; pH 7) and monitored by UV-vis spectroscopy
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Figure 111-3. (a) Changes in the electronic spectra of the H39C variant with addition of
imidazole (100 mM). The final spectrum (Soret 414 om) is typical of bis-imidazole
ligation to ferric heme. (b) UV-vis spectrum of WT OM cyt bs that shows bis-histidine
ligation.
--
-(Figure 3). A total of 15 ~L of imidazole (2000x molar excess) was added in order to
shift the Soret maxima to 414 nm from 422 run. The final spectrum of H39C-Im is
indicative of bis-histidine type ligation to a heme iron such as that in WT OM cyt b5
(Figure 3b) [1). This experiment also indicates that the heme pocket in H39C is
accessible to small molecules. Furthennore, the experiment also suggests that the sixth
ligand (Cys39) is weakly bound to the heme due to facile replacement by imidazole.
Addition of K3Fe(CNk During early investigations of the H39C variant, it was
not clear if the freshly purified protein possessed a reduced heme iron (Fe2+) or an
oxidized heme iron (Fe3+). The oxidizing agent K3Fe(CN)6 was utilized in attempt to
elucidate the oxidation state of the iron. The absorption spectrum of H39C in buffer
containing 3 mM K}Fe(CNh exhibits a broad Soret with a slight peak at 410 nm (data not
shown). Subsequent removal of the excess K}Fe(CN)6 with the aid of a size exclusion
chromatography yields a spectrum with a sharp Soret at 408 nm, a small ~ band at 532
nm, and a high-spin marker at 636 nm (Figure 4). The shape of the pectrum is almosl
identical to WT Mb (Figure 2) [2], thus suggesting that the axial ligation of the 1-139C
variant treated with the oxidizing agent K}Fe(CN)6 is a proximal histidine and a dislal
H20. The spectrum is also similar to high-spin P-450cam , whose proximal ligand is a
cysteine. However, several researchers conclude that a Soret peak less than 400 nm is an
indication of thiolate ligation to a heme [10, 11]. It is therefore likely that K}Fe(CN)6
oxidized the coordinated thiolate of Cys39 to a species that could not coordinate the ferric
heme iron, or that the thiolate of Cys39 cannot coordinate the ferric heme iron in the
mutant.
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Figure 111-4. Electronic spectrum of H39C obtained by addition K)Fe(CN)6 (0.05 M) Lo
a sample of H39C and subsequent removal by gel-filtration chromatography. This
resulting spectrum is typical of a high-spin ferric hemeprotein with histidine as the axial
ligand.
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Ferrous H39C
Characteristics of Fe(I1)-H39C. Other researchers have used Mb (human and
horse heart) in attempt to model this ligation found in P-450cam [11, 12]. Limited success
with some mutants has yielded thiolate-ligation in the ferric states, but retaining the
thiolate upon reduction of the iron has not been achieved with these mutants. Following
this trend, reduction of H39C with dithionite, (Figure 5) reveals a spectrum like that of
ferrous Mb (Figure 2). The Sorel is slightly broadened at 428 nm, with only a single
absorption in the visible region at 556 nm. The spectrum resembles a five-coordinate
high-spin iron ligated by a single histidine, likely the endogeneous ligand His63 in the
case of H39C. In light of this evidence, it appears that thiolate ligation to the iron is not
retained upon reduction. The thiolate side chain of the cysteine residue is shorl in
comparison to that of histidine, which could significantly contribute to the weak
coordination to the ferrous heme iron.
The Fe(I1) form of H39C-Im. The reduced spectrum of H39C-lm reveals a
low-spin six-coordinated heme iron. The Soret peak is at 424 nm with very strong a and
~ bands at 558 and 528 nm, respectively (Figure 6). The spectrum is nearly identical to
the ferrous species of OM cyt b j , which is low-spin bis-histidine ligated [I].
The Fe(I1)-CO form of H39C. A final confirmation of thiolate ligation to a
ferrous heme is the unique shape of the ferrous CO spectrum. In the case of P-450cmTh
upon addition of CO in a reducing envi ronment, a spectral transition of the Soret peak to
448 nm takes places, thus the name P-450cam . The Fe(II)-CO spectrum of H39C does not
reveal thiolate ligation (Figure 7). Instead, the Soret is sharpened and greatly increased at
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418 run with equally intense a and Pbands at 570 and 538, respectively. These peak are
characteristic of His and CO acting as axial ligands.
Comparison to other Fe(IIKO heme proteins. Several ligand mutant of Mb,
along with P-420cam , C-420, and CooA also reveal a spectrum not typical of thiolate
Fe(II)-CO coordination [5, 6, 13]. The inability to produce a P-45Q-CO-type spectrum
with the H39C variant and the other heme proteins mentioned above indicate that the
presence of a thiolate in the heme pocket does not preclude ligation to the heme. It
suggests that several factors, such as proximity of the cysteine to the iron, the presence or
absence of a distal ligand, or the oxidation state of the cysteine itself, could playa role ill
facilitating or maintaining the ligation of the thiolate.
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CHAPTER IV
OM cyt bs H63C
Low-spin Fe(lII) H63C
Electronic characteristics of low-spin H63C. The histidines at positions 39 and
03 cannot be assumed to contribute equally to the heme iron a ligands. Therefore,
replacing the histidine at position 63 with a cysteine will impart different influences on
the heme environment, which could favor ligation of Cys63 in the different oxidation
states of the heme iron (Fe3+ and Fe2+). The electronic spectrum of the H63C variant of
OM cyt bs exhibits similar peaks, and in general is very similar to that exhibited by the
H39C variant (Figure la). The prominent Soret band is at 422 run, a S band at 360 nm,
and a a. band at 570 run that is a shoulder to the P band at 540 nm. A unique
characteristic of low-spin thiolate-ligated heme proteins is absorption near 750 nm [1],
which is also a feature of the H63C variant (Figure 1b).
The H63C variant is stable over a pH range 5.0 to 10.0 and does not demonstrate
spectral shifts characteristic of protonation or deprotonation in thi pH range. Spectral
shifts have been observed in Mb and other heme proteins due to deprotonation of an axial
ligand [2-4]. In addition, spectral shifts due to changes in conformation, ligand binding,
or denaturation are not observed over the temperature range 4-48 0c.
Effects of the addition of cyanide and imidazole. Imidazole was utilized to
gain insight to the accessibility of the heme pocket and to probe the nature of the sixth
ligand. Cyanide (in the form of aCN) and imidazole (lm) were titrated into solutions
containing H63C and monitored by UV-vis spectroscopy. The addition of NaCN did not
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Figure IV-I. (a) UV-vis spectrum of low-spin Fe(IIl) H63C. (b) Region of the
spectrum showing the ligand-to-metal charge-transfer bands characteristic of thiolate
ligation.
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produce any spectral shifts, indicating the heme axial position Irans to His39 is not
available for ligation to produce H63C-CN, or that C - is unable to replace one of the
axial ligands. Thus, Cys63 is likely to be bound in the axial position.
The addition of 1m. however. does induce spectral shifts in H63C (Figure 2).
Small aliquots of 1m (5 ~L, 100 mM) were added to a protein solution and allowed to
react for several minutes. The final spectrum reveals a protein with bis-histidine type
ligation. This is indicated by an increase Soret band absorption at 414 om, accompanied
by a marked decrease in the 8 band (360 nm), with essentially no alterations in the visible
region. The spectral shift occurred over 30 min. The relatively slow rate with which the
spectral shifts occur are most likely due to a combination of reduced accessibility to the
heme (as compared with the high-spin penta-coordinated forms of the variants) and
displacement of the existing ligand, Cys63. The lack of changes observed in the visible
region indicates a spin shift is not induced; the addition of 1m maintains a hexa-
coordinated heme.
EPR spectroscopy. Electronic paramagnetic resonance (EPR) was used to
corroborate thiolate as the sixth ligand in H63C. The g values observed at 2.415, 2.258.
and 1.916 agree with several heme proteins that possess thiolate as a ligand to the heme,
see Table 1.
Discrepancies among the g values of these proteins that share similar axial
ligation to the heme may arise from the cysteine of H63C being partially oxidized to
cysteinsulfinic acid (Scheme J). The partial oxidation of Cys63 could lead to a mixture of
spin-states and therefore slightly alter the g values from those proteins possessing a
majority of a single spin-state.
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Figure IV-2. Changes in the Soret peak of low-spin Fe(III) H63C with the addition of
imidazole (100 mM). The final spectrum (Soret 414 11m) reveals bis-imidazole ligation to
the heme. The loss of ab orption at 360 nm indicates loss of the thiolate ligand.
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-Table IV-I. EPR Spectral Parameters ofThiolate-Ligated Low-Spin Heme Proteins
protein g, g2 g3 ref.
Fe(III)H63C 2.415 2.258 1.916 this work
Fe(III)P-450cam 2.45 2.26 1.91 [5]
Fe(III)P-420cam 2.45 2.27 1.91 [6]
Fe(III)C-420 2.48 2.27 1.89 [3]
Fe(III)CooA 2.46 2.25 l.89 [7]
Scheme I
Cysteinate Cysteinesulfinic Cysteic acid
High-spin Fe(III) H63C
Electronic characteristics of high-spin H63C. A high-spin form of H63C (HS
H63C) can be induced by removal of the sixth ligand (Cys63) as in the H39 variant.
The electronic spectrum of this high-spin form closely resembles WT Mb with a sharp
Soret peak at 404 11m, a shoulder at 498 nm, and a high-spin marker at 626 nm (Figure 3).
The shape of the spectrum is consistent with a water trans to a histidine as the h me axial
ligands [4].
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Formation of high-spin H63C during addition of heme. The appearance of HS
H63C came about during an attempt to incorporate additional heme following the
purification process. The diminished ability of the polypeptide to incorporate heme
during expression and purification is a common problem when mutating the amino acid
that act as the axial ligands to the heme [8], and can normally be overcome by
incorporating heme after purification. An indicator of the holoprotein concentration is
the absorbance ratio of the band at 280 nm versus the Soret band. Purifications of WT
OM cyt b5 consistently yield ratios (A2801A 423 ) of 0.2 ±0.01 [9], however, purifications of
the H63C variant yielded ratios (A280IA422) of 0.8-1, thus suggesting the pre ence of a
mixture constituting of holo- and apo-proteins. In order to incorporate heme into th
apoprotein, a solution containing heme (1 mg/mL), prepared from either hemin chloride
or extracted from Mb, was titrated into a dilute solution of H63C and monitored by uv-
vis spectroscopy. A plot of the Soret band absorption versus total amount of heme added
was used to determine the limit of incorporation. Within the first additions of heme, the
Soret peak dramatically shifted and eventually sharpened and increased to 404 nm
(Figure 4). Excess (unincorporated) heme was removed by concentrating the volume to
1-2 mL and then applying the protein solution to a size-exclu ion chromatography
column. The resulting spectrum is shown in Figure 3.
High-spin Fe(III) H63C-CN. The small molecule cyanide was again used to
probe the heme pocket of HS H63C. A few cry taLs of NaCN (3 mg; 50% excess) was
added to H63C and monitored by UV-vis spectroscopy. The resulting spectrum (Figure
5) shows a Soret peak at 418 nm with a concomitant decrease in the high-spin marker at
636 nm and the appearance of discernable visible bands. There was essentially no
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Figure IV-4. Family of spectra shows the changes to low-spin H63C with the titration of
heme. The addition of heme induces a spin state change (420 nm to 404 nm) of the
Fe(lH). Excess heme is responsible for the broad absorption at -360 nm.
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Figure IV-5. Changes to the spectrum of high-spin H63C (..... ) with addition ofCN-.
The resulting spectrum (-) indicates a spin-state change with the coordination of CN- to
the heme.
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-additional change observed in the spectrum 10 min after addition of aCN. The removal
of the new axial ligand (C -) was accomplished by exhaustive dialysis. The resulting
spectrum was the typical HS H63C variant (Figure 6).
High-spin Fe(III) H63C-Im. In the same fashion as cyanide, 1m readily binds
the heme as the sixth ligand (Figure 7). This spectrum is typical of a protein with bis-
histidine type ligation to the heme [2, 9]. The rate with which 1m binds HS H63C is in
sharp contrast with the slow spectral shifts observed as in the addition of 1m to LS H63C.
Moreover, while 1m does bind the heme in the LS form, larger excess is required as well
as a longer period to observe the final conversion (30 s vs. 30 min) (Figure 7 and Figure
2) because ofreplacement of the existing axial ligand Cys63.
EPR spectroscopy of high-spin H63C. The EPR spectrum of HS H63C reveals
g values (5.909 and 2.233) typical of a high-spin heme protein with ligation similar to
metmyoglobin (5.99 and 2.00). The lack of rhombic splitting in the EPR spectrum
indicates Cys63 is not ligated to the heme in HS H63C [10].
Oxidation of cysteine. Ferric iron (Fe3+) can exist in two spin-states, S= I/2, low-
spin (LS) in which the five 3d electrons are maximally paired, of S=5/2, high-spin (HS)
in which the five 3d electrons are maximally unpaired. Intermediary spin states, while
possible, are not normally found in biological systems. In the heme system, hexa-
coordinated Fe3+ is generally fount to be LS and penta-coordinated Fe3+ is found in the
HS state.
In addition to the HS form being formed upon addition of heme (see above), the
HS form of H63C can also be observed after a period of time and without any chemical
influence. That is, the purified low-spin (LS) protein gradually looses an axial ligand and
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Figure IV-7. Changes in the spectrum of high-spin H63C with the addition of imidazole.
The shift in the Soret (404 run to 412 nm) and the loss of the high-spin marker (626 nm)
indicates a spin-shift with the binding of imidazole to H63C.
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undergoes a spin-state change. The appearance of the HS form and the ease at which it is
induced can be attributed to a number of factors. Factors such as weak Fe-S(thiolate)
interaction, the cysteine being slowly oxidized to a species that cannot bind herne, or
dimers forming due to cys-cys bond formation. Dimer formation due to cys-cys bonding
was ruled out by experiments detailed below.
Oimer formation ruled out by glutathione. Glutathione is a tri-peptide that is
able to break disulfide bonus. but b~cause of its size cannot act as an axial ligand to the
heme [5]. A 10-roM solution of the tri-peptide (glutathione) was prepared in buffer and
an aliquot (20 ~L) was added to a protein solution and allowed to react for 1.5 h while
monitored every 30 min by UV-vis spectroscopy. No change was observed from the
initial spectrum (data not shown).
Dimer formation ruled out by size-exclusion chromatography. An additional
analysis for possible dimer formation was the utilization of a size-exclu ion
chromatography column. A mixture of HS H63C and WT OM cyt bs was applied to a
Sephadex G-50 column. The column was monitored visually for the appearance of two
bands of protein that would separate based on differences in Mr. The HS H63C dimer is
expected to travel at a faster rate than WT OM cyt bs through the column. The mixture
passed through the column as a single band. An absorption spectrum (data not shown)
revealed no modifications to the proteins. The glutathione and chromatography
experiments show that dimers are not likely the cause of the spin-state change from low-
spin to high-spin H63C.
The effect of OTT on high-spin H63C. An additional experiment was
conducted to explore possible dimer formation that yielded the most interesting results.
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Dithiothreitol (OIT) is commonly used as an agent to reduce disulfide bonds. The
electronic spectrum of the H63C variant showed a spin-state change with the addition of
DTT (Figure 8). The spectrum is the typical low-spin form of H63C. Previou
experiments show no dimer formation; therefore, the OTT must be acting in a different
capacity than breaking disulfide bonds. DTT has been shown to act as a ligand in P-
450cam, but with distinct spectral characteristics such as split Soret peaks that are not
observed in H63C PI]. Exhaustive dialysis produced no spectral changes from L
H63C, which indicates that OTT is not a ligand, but instead facilitates the binding Cys63
to the heme. Although DTT was able to restore H63C to a low-spin, thiolate-Iigated type
protein, the conversion was less efficient than that of a freshly purified sanlple. The
absorbance ratios (A 280IA 420) of low-spin samples prepared from OTT titrations were 0.9
or greater (Figure 9). Since DTT is a reducing agent, it is possible that it is reducing
Cys63 to a species that is capable of binding the iron, either cysteine, Of possibly
cysteinsulfinic acid. The unfavorable ratio values are consistent with loss of an axial
ligand caused by the Cys63 being oxidized (Scheme I) and consequently, OTT being
unable to reduce it. In addition, freshly purified aliquots of H63C that were stored in the
presence of DTT and purged with an inert gas did not show the gradual tran formation to
the high-spin form as with samples not stored in this manner. DTT decompose quickly
in an O2 environment and is more efficient at pH 8 than pH 7 and at lower temperatures.
Thus, protein solutions that were maintained with conditions semi-anaerobic, phosphate
buffers adjusted to pH 8, and stored at 4 °C exhibited no appreciable spectral changes
over time.
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Figure IV-8. Family ofUV-vis spectra showing a spin-state change in Fe(llJ) H63C
with the titration of OTT. The low-spin form is apparent in the Soret at 420 run and the
disappearance of the high-spin marker at 630 nm.
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48
--
Identification of the sixth ligand in Fe(lII) H63C
Evidence for thiolate as the sixth ligand to Fe(I1I) in H63C. Evidence ba ed
on EPR and UV-vis spectral data indicates LS H63C having a thiolate-derived ligand
trans to His39. The g values of lS H63C (2.415, 2.258, and 1.916) agree with other
thiolate-ligated proteins (Table 1) as well as specific characteristics of the UV-vi
spectrum (8 peak at 358 to 360 nm and a thiolate peak at 750 nm). These characteristics
strongly indicate that H63C does have a cysteine-derived ligand. However, the nature of
the cysteine (thiol or thiolate) is not known for certainty, but is presumed to be a thiolate
based on research by Sono and co-workers [12] who determined the cysteine of P-450cam
to be a thiolate. The behavi.or of H63C in the presence of OTT indicates that the thiolate
of the Cys63 is first oxidized in the normal environment of the protein solution and
subsequently reduced when OTT is present, thereby facilitating binding to the heme once
again. An additional experiment utilizing ascorbic acid corroborates the reducing effect
of OTT on Cys63.
Addition of ascorbic acid to H63C. Ascorbic acid has been used as a reducing
agent in other variants of OM cyt bs [8], however ascorbic acid does not reduce the heme
iron in the H63C variant. Incubation of lS H63C with 5 ilL of a solution of ascorbic acid
(1 M) produces no spectral shifts. In contrast, incubation of HS H63C with ascorbic acid
does induce a spectral shift. A I-Ill aliquot of ascorbic acid (I M) was added to a
solution containing HS H63C (319 .uM) and monitored by UV-vis spectroscopy over
nine hours. The resulting family of spectra (Figure 10) shows a slow shift in the Soret
band from an initial value of 404 nm to 420 nm with a concomitant decrease in
absorption. In the visible region, a. (568 nm) and ~ (538 nm) peaks emerge as the high-
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Figure IV-10. (a) Electronic absorption of H63C with the addition of ascorbate (1 M) to
a sample of high-spin Fe(III) H63C. The initial Soret (404 nm) steadily decreases then
increases to 420 nm, while passing through an isobestic point at 414 nrn. (b) UV-vis
spectrum resulting 9 h after addition of ascorbate to high-spin H63C. The addition
induces a spin-state change (404 nm to 420 nm) in the heme iron.
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spin marker (630 run) disappears. The appearance of a 8 band (354 run) is also observ d.
The final spectrum reveals LS H63C (Figure lOb). The results of this experiment suggest
that ascorbic acid is acting upon Cys63 in the same manner as DTT, that is, reducing the
ligand Cys63 which, in tum, binds to the heme.
Oxidation of cysteine. Several oxidation products of the protein thiol(ate) group
can be formed [13]. Oxidizing agents can convert thiol(ate)s to disulfides or to higher
oxidation products such as sulfinates or sulfonates. In order for disulfides to form in OM
cyt bs, the protein would have to form dimers, which have been ruled out by experiments
previously detailed (See above). Therefore, the thiolate of Cys63 must be converted to
higher oxidized monomeric products (Scheme I). Once the thiolate is oxidized, OTT or
ascorbic acid is able to reduce it, thus facilitating binding to the heme, which is seen
spectroscopically as a spin-state change from high-spin to low-spin heme iron.
Mass spectrometry of H63C
Mass spectrometry has been utilized by others to probe for modified amino acids
following oxidation [14-16]. The technique is able to determine if cysteine have been
oxidized to cysteic acid by reporting a mass 48 Oa larger than expected. Moreover, the
peptides analyzed by the researchers were subject to harsh oxidants such as performic
acid and peroxide [14, 17].
The thiolate of Cys63 in the H63C variant is proposed to undergo oxidation
(Scheme 1), which ultimately results in loss of an axial ligand. Furthermore, the thiolate
undergoes this oxidation in the absence of harsh oxidants. These oxidation products of
Cys63 in H63C were detem1ined by mass spectrometry.
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LS H63C. The low-spin form of the H63C variant is proposed to po es a
thiolate as an axial ligand, therefore the majority of Cys63 should be in the form of a
thiolate. As stated above, the mutant gradually undergoes a spin-state transition due to
loss of a ligand without any influence other than time and exposure to air.
The low-spin form of the variant to be sent for mass analysis was prepared from a
standard expression of the H63C variant. To minimize the gradual oxidation of the
Cys63 ligand, the freshly purified protein was aliquoted with some aliquots made I mM
DTT. Samples were flash frozen in liquid nitrogen and stored at -20°C. This storage
process dramatically slows or prohibits the autooxidation of Cys63 as evidenced by a
persistent low-spin spectrum. The sample to be analyzed by mass spectroscopy was
dialyzed against NH4HC03 buffer (50 mM; pH 8.5) for 18 h at 4 0C. The solution was
kept semi-anaerobic by bubbling with an inert gas throughout the dialysis. Spectroscopic
analysis reveals a protein to be majority low-spin (Figure 13)
Figure 11 shows the mass spectrum of low-spin H63C. The mass of the 1-163
variant is 10,475.4 Da. Mass analysis of LS H63C confirms that the majority of the
ligand Cys63 remains cysteine (m/z = 10,475). Partial oxidation of the ligand, however,
is seen in the form of cysteinsulfinic acid (m/z = 10,507; + 32 Oa) and cysteic acid (m/z =
10,524; +49 Oa).
HS H63C. The high-spin form of H63C is brought about by loss of the axial
heme ligand Cys63. If the loss of the ligand is due to oxidation of the cysteine, then a
mass analysis should reveal its oxidation products. The high-spin sample for mass
analysis was prepared by dialysis against NH4HC03 buffer (50 mM; pH 8.5) for 24 hat 6
0C. The sample was prepared from an aliquot that did not contain OTT. Also, the
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Figure IV-l1. Mass spectrum of low-spin H63C. The inset shows the expanded peaks that correspond to the apoprotein (10475.4
Da). The predominant peak is consistent with Cys63 in the form of a cysteine(ate). The less predominant peaks indicate that the
cysteine is partially oxidized to cysteinsulfinic acid (+32 Da Ys. H63C) and cysteic acid (+49 Da ys. H63C)
100 431
%
H63Cw/o on
after 10: 1 dil in 50%
ACN 0.1% HCOOH
499
567
635
703
809
877
956
1052
1168
Scan ES+
100 105 7.00 Cysteinsulfinic acid
1 524.00 Cysteic acid
%
10623.00
o m~
10500 10750 11000 11250 11500
1314
1502
Figure IV-12. Mass spectrum of high-spin H63C. The expanded inset indicates the predominant peak at +32 Da vs. H63C
(10,475.4 Da). The extra mass is attributed to two molecules of oxygen that is explained by the oxidation of the cysteinate to
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dialysis buffer was not degassed. The protein denatured with prolonged exposure to the
buffer at room temperature, thus the dialysis was performed at 6 dc. The UV-vi
characteristics of the sample are shown in Figure 13. A small absorption at 361 nm
persists, and the Soret peak is not as sharp as in other preparations of HC H63C.
The mass spectrum of HS H63C (Figure 12) shows the thiolate of Cys63 has been
oxidized. The majority of oxidation products appear as cysteinsulfinic acid (m/z =
10,507; + 32 Da) with a smaller fraction of cysteic acid (m/z = 10,524' +49 Da). This is
the first evidence utilizing mass spectroscopy of a thiolate axial ligand in a hemeprotein
being oxidized without any influence other than time and exposure to air.
Oxidation of cysteine to cysteic acid is not reversible.
The mass spectrometry data clearly shows the thiolate side chain of Cys63 is
oxidized to cysteinsulfinic acid and cysteic acid. This data, taken together with the
results of the experiments utilizing OTT show the spin-state change that occurs in the
mutant is due to oxidation of the Cys63 axial ligand, which cannot bind heme. Likely,
once the cysteine is oxidized to cysteic acid, OTT (or ascorbate) cannot reduce it.
However, it does seem likely that when the oxidation product j cystein ulfinic acid, OTT
(or ascorbate) is able to reduce it to cysteine, thus facilitating the binding to the heme
once agam.
Evidence of the inability of OTT to reduce cysteic acid is the observed change in
the relative absorbance of the Soret band (420 nm) after the addition of DTT. As
discussed previously and illustrated in Figure 9, a low-spin sample of H63C prepared by
addition of DTT (to a high-spin sample) has a much lower relative absorbance of the
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Soret band than the Soret band of a sample of freshly purified H63C. Apparently, OTT is
able to successfully reduce the cysteinsulfinic acid but not cysteic acid. The absorbance
ratios (A2801A 42o) of the spectra in Figure 9 also reflect the inability of DTT to reduce
cysteic acid. If OTT were able to reduce cysteic acid to a species capable of binding
heme (cysteine), then the expected absorbance ratio (A2801A42o) would be near that of a
freshly purified sample « I), which would have a minimum amount of cysteic acid
present.
Ascorbate addition to HS H63C, aerobic vs. anaerobic addition.
The addition of ascorbate to the high-spin form of the mutant reveals the same
behavior as the addition of OTT to the high-spin form as discussed above. Figure 10
shows the spin-state change brought about when ascorbate is added aerobically and
Figure 14 shows the spin-state changes in the UV-vis spectrum when ascorbate is added
to HS H63C under strict anaerobic conditions. The result of both additions (see insets
Figure lOb and Figure 14b) is a spin-state conversion form high-spin to low-spin with
similar absorban.ce ratios (A280/A420). Again, the addition of ascorbate to the high-spin
form of the mutant is proposed to reduce the oxidized Cys63 to cysteine and therefore
initiate the spin-state change by facilitating binding of Cys63 to the heme as observed
with the addition of DTT.
There is a striking difference in the spectra between the anaerobic addition of
ascorbate (Figure 14) versus the aerobic addition (Figure 10). The addition of ascorbate
in aerobic conditions induces a spin-state change that proceeds through a clear isobestic
at 4]4 run while the anaerobic addition of ascorbate (Figure 14) involves the gradual
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Figure IV-14. (a) Changes in the electronic spectrum of high-spin Fe(III) H63C with the
addition of ascorbate under anaerobic conditions. After 12 h the Soret has shifted and
decreased in intensity from 404 nrn to 420 nm. (b) Final spectrum 12 h after the addition
of ascorbate in anaerobic conditions.
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formatiun of the low-spin protein without passing through and isobestic. The lack of a
clear isobestic in the case of anaerobic reduction of Cys63 indicates complex transition
states that are not apparent when Cys63 is reduced with ascorbate in air.
A possible explanation for the differences may lie in the preparation of the initial
high-spin forms of the H63C variant. As discussed previously, adding heme to a solution
of freshly purified protein brings about the high-spin form. Normally the addition of
heme to the freshly purified protein brings about an immediate spin-state change to the
high-spin form. At this point, it is impossible to quantifY the amount (or identity) of the
oxidation products of the Cys63 cysteine. Of course mass analysis can be utilized,
however, the sample is destroyed in the process. Strict laboratory procedures are
followed to ensure uniformity among the expressions and purifications of H63C,
however, too many variables exist to ensure that each expression and subsequent
purification of the protein is an exact duplicate. As a result, preparations of the high-spin
form may not be highly reproducible. The difference in the spectra between the two
ascorbate additions could be because the experiments were preformed on different
expressions and purifications of H63C.
.Molar Absorptivity
Concentrations of HS H63C were calculated usmg the molar absorptivity
coefficient determined by the pyridine hemochrome method (E404 = 106 mM- 1 em-I) [18].
The molar absorptivity of the low-spin form of the variant could not be determined by the
pyridine hemochrome method due to Cys63 existing in several oxidation states.
5<)
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Ferrous H63C
Characteristics of Fe(II) H63C. The ferrous form (Fe2+) of the variant was
obtained by the addition of dithionite either in the presence of oxygen, or anaerobically
by the addition of a deoxygenated solution of dithionite (10 mM). The resulting
spectrum of ferrous H63C (Figure 15) was obtained regardless of the spin-state of ferric
H63C being reduced. In contrast to ferrous H39C (Chapter III Figure 5), the spectrum of
the reduced H63C variant shows a typical low-spin ferrous heme that is hexa-
coordinated. The spectrum of ferrous H63C suggests the thiolate is retained upon
reduction. Further evidence for Cys63 as a ligand to the ferrous heme is indicated by a
lack of spin-state change when the ferrous heme is allowed to autooxidize (Fe2+ to Fe3+).
The result is ferric LS H63C with its typical low-spin shape. Since ferrous H63C does
not revert to a high-spin protein upon autooxidation, the previous explanation of Cys63
being reduced to a species able to bind heme is logical. Furthermore, since dithionite is a
strong reducing agent, the iron of the heme is reduced as well as Cys63. This i in
contrast to ascorbic acid and DIY, which cannot reduce the iron of the heme. Oxygen is
ruled out as the ligand frans to His39 in ferrous H63C because a sample that was
deoxygenated and kept strictly anaerobic produced the exact spectrum when reduced
(with dithionite) as the spectrum of a sample with O2 bubbled during the addition of
dithionite.
Comparison to other Fe(lJ) hemeproteins. Table II shows similarities of UV-
vis characteristics of several ferrous forms of heme proteins that possess cysteine as a
ligand in the ferric form Interestingly, ferrous H63C does not resemble P-450CAM, but
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Figure IV-IS. UV-vis spectrum of Fe(II) H63C. The shape of the visible region
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axial ligands to the heme.
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does closely resemble the inactive form P-420CAM, as well as the ferrous forms of C-420,
CooA, and WT OM cyt bs, and the H93C/H64V variant of Horse Heart Mb. The e
proteins, with the exception of WT OM cyt bs, possess a thiolate as a ligand in the ferric
form. Researchers conclude that in the cases of P-420 AM, C-420, and the Mb variant the
thiolate ligand is either lost or protonated upon reduction [3, 6, 19]. For H63C, the
ligands available for producing a low-spin ferrous heme are histidine (Hi 39) and
cysteine (Cys63). If the cysteine were not bound (even weakly), then a spectrwn
resembling Fe(II) H39C would likely be the result whose ligation is likely a water trans
to His63. Thus, revealing a dramatically different spectrwn.
Determination of protonation of thiolate upon reduction. To test for possible
protonation of the thiolate upon reduction, two experiments were conducted. In one
experiment, a sample of HS H63C (6.4 IJ.M) was exchanged for phosphate buffer (pH 9.0;
50 mM) and anaerobically reduced with a deoxygenated solution of dithionite (10 mM).
The experiment was monitored speclroscopically for 24 h. The initial spectrum after the
addition of dithionite was typical ferrous H63C with essentially no change over 24 h
except for a small decrease in overall intensity, This experiment indicates Cys63 is either
previously deprotonated or that pH 9.0 is not sufficient to deprotonate the ligand. In a
similar experiment, a NaOH solution (0.5 M) was titrated into an anaerobic solution
containing ferrous H63C (9.3 IJ.M). The experiment wa monitored by UV-vis
spectroscopy utilizing an airtight cuvette. No significant changes in the Sorel or visible
bands were noted until the concentration of NaOH in the reaction vessel reached - 30
)1M. At this point, the Soret rapidly began losing intensity, which is likely attributable to
denaturation of the protein that can occur in a very basic environment. The final solution
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-had a pH 11.91 and the general shape of the spectrum of the protein persisted with a Soret
66% of the initial absorption. These experiments show that if Cys63 is an axial ligand to
the ferrous heme, then it may already be deprotonated (a cysteinate), or deprotonation
does not cause a change in the spectrum. It is likely Cys63 is bound (weakly) to the
ferrous heme in H63 C, or the presence of the thiolate in the heme pocket is sufficient to
stabilize the low-spin ferrous form of H63C.
Table 1\'-2. UV-vis spectral data for heme proteins.a
protein Soret (nm) ~ (nm) a (11m) ref.
Fe(II)H63C 424 528 558 b
Fe(II)CooA 426 529 559 [20]
Fe(II)P-420calll 424 530 558 [6]
Fe(II)C-420 425 530 555 [3]
Fe(II)OM cyt bs 423 526 556 [9] 'sI...
ii
,.
Fe(II)H93C/H64V Mbc 427 545 570 [ 19]
Fe(II)P-450cam 411 540 [21 ]
apeak positions are reported in nanometers. bThis work. cHorse heart Mb.
63
-The Fe(II)-CO form of H63C. The ferrous CO spectrum of LS H63 C is .typical
of a hemeprotein without cysteine as a ligand (Figure 16). The Soret peak is increa ed in
intensity and sharp at 418 nm with equal intensity a (538 nm) and P (568 nm) bands.
The spectrum is typical of a hemeprotein with a histidine and CO as the ligands to the
heme, as in Fe(II)-CO Mb [4]. Clearly, CO readily displaces Cys63 in the reduced iron.
Thus, lending more evidence that Cys63 is weakly bound to the heme and is readily
displaced by small molecules in a Fe2+ heme environment.
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Figure IV-16. UV-vis spectrum of Fe(II)-CO H63C. The Soret band (418 nm) is
consistent with histidine and CO as the axial ligands to the reduced iron of the heme.
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CHAPTER V
OM cyt hs H39V/H63C
Comparison with myoglobin (Mb) mutants
The H39C and H63C variants have failed to achieve ligation like that of the
carbon monoxide ferrous form of P-450 (Soret band at 450 nm). Furthermore, a high-
spin ferric species with cysteine as the axial ligand instead of histidine was not produced
through the singJe Jigand mutations. Similar conditions prevailed when Hildebrand and
co-workers produced single variants of horse heart myoglobin (Mb) [1]. Only when the
distal histidine, in addition to the proximal histidine, was mutated a ferric high-spin
species with cysteine as the ligand to the heme was revealed in horse heart Mb. Due to
the limited success of this double mutant of Mb (H64V/H93C), a double mutant for OM
cyt bs was designed. Based on the observations of the two previous single variants, it
was determined that the H63C variant provided more desirable characteristics of cysteine
ligation to the heme than the H39C variant. Therefore, the histidine at position 39 would
be mutated for an amino acid that could not act as an axial ligand to the heme, a valine.
Experimental
The double mutant H39V/H63C for OM cyt bs was produced by annealing three
oligonucleotides (two mutagenic, one selection) in the same reaction mixture instead of a
stepwise approach of annealing only one mutagenic primer at a time (See Chapter II).
The expression of the H39V/H63C variant was carried out as previously detailed in
Chapter II with the exception that all buffers and solutions through the ion-exchange
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process were maintained 1mM imidazole (lm). A purification without 1m present wa
attempted, however the result of expression was cells that yielded modest color attributed
to heme. Furthermore when the lysed protein solution was applied to the ion-exchange
column, the characteristic red color, although weak, gradually disappeared. This
indicates that H39V/H63C variant loses the heme, which is likely due to a significantly
weak heme complex as compared to the two other ligand mutants (H39C and H63C).
Since the expression itself (with 1M present) yielded lightly colored cells, more so than
expressions of the previous variants, heme was incorporated prior to chromatography
purification. The protein was collected from the size-exclusion chromatography step and
subsequently concentrated and exchanged for 50 mM potassium phosphate buffer (pH
8.5). The UV-vis spectrum indicates characteristics of a low-spin thiolate ligated protein
(Figure la). The spectrum indicates that cysteine and 1m are the likely ligands to the
heme. The slight absorption at 735 lUTI (Figure lb) is conformation ofthiolate ligation to
the heme [2]. Unfavorable ab orbance ratios (A280/A422 > I) existed due to the loss or
heme during the purification. Therefore, heme (I mg/mL) was added in an attempt to
decrease the absorbance ratio. However. the purified H39V/H63C variant would not
incorporate heme. Since the H63C variant readily incorporated heme with a spin-state
change and subsequent loss of the Cys63 ligand, the protein-derived ligand (His39) likely
plays a major role in incorporation and stability of additional heme. The H39VIH63
variant lacks this critical protein-derived ligand due to His39 being mutated for a valine.
Consequently, additional heme could not be incorporated.
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Figure V-l. (a) UV-vis spectrum of the low-spin Fe(IIl) H39V/H63C variant. (b)
Region showing the ligand-to-metal charge-transfer band indicating thiolate ligation.
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-Ferric H39V1H63C
Dialysis. According to spectroscopic evidence, the protein has two ligands (hexa-
coordinated) to the ferric heme, likely Cys63 and 1m. Attempts were made to dialyze the
protein in order to obtain a penta-coordinated ferric species with Cys63 as the lone axial
ligand to heme. Due to the tendency of the cysteine to become oxidized as displayed in
the H63C variant, the dialysis was carried out under semi-anaerobic conditions. A stream
of N2 gas was bubbled in the dialysis solution (50 mM potassium phosphate; pH 8.5)
prior to and during the dialysis experiment. The protein solution was monitored
periodically by UV-vis spectroscopy. Figure 2 shows a family of spectra taken over a
24-hour period. The loss of the () band at 360 nm with the concomitant decrease in the
Soret band (422 nm) intensity indicates the protein is no longer thiolate-ligated. In
addition, denaturation could be occurring due to the dialysis buffer at pH 8.5. An
additional dialysis experiment in potassium phosphate buffer (50 mM) with pH 7 was
performed to rule out effects due to denaturation. The dialysis performed at pH 7 was
subject to the conditions outlined for the previous dialysis experiment. The protein was
monitored by UV-vis spectroscopy over a period of 32 hours. Figure 3 shows the family
of spectra taken during the dialysis. The steady decrease in intensity of the overall
spectrum, in addition to the Soret band shift, indicates a loss of Cys63 as an axial ligand
and a loss of heme as well. The dialysis experiments show that the H39VIH63C variant
is likely not capable of adopting a penta-coordinated ferric species with thiolate-derived
Cys63 as the axial ligand to heme.
Addition of ~-mercaptoethanol. Since the ligand lrans to Cys63 in the
H39V/H63C variant (1m) is not protein-derived, then it can potentially be replaced by
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Figure V-3. Family of spectra taken during dialysis of H39V/H63C (50 mM potassium
phosphate; pH 7). The final spectrum indicates a spin-state change due to loss of the
thiolate-derived ligand, Cys63, In addition, the I.oss of intensity of the Soret band
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-another ligand. Sono and co-workers [3] studied sulfur donor ligand binding to P-450 M
and Mb. They reported V-vis spectral data for p-mercaptoethanol (a thiolate). They
found that on binding to P-450, the thiolate cause the spectral properties of the enzyme to
change from "normal" (single Soret peak maximum at -420 nm) to "hyper" (split oret
peaks at -380 and -460 nm). Thus, titration of p-mercaptoethanol provid a imple
method for determination of two sulfur donor axial ligands to heme proteins. Figure 4
shows the family of spectra obtained upon the addition of p-mercaptoethanol to the
H39VIH63C variant. The experiment was conducted in an anaerobic environment
utilizing an airtight cuvette fitted with a septum with the entire apparatus in a refrigerator
held at 6 0c. The protein solution was in 50 mM potassium phosphate buffer (pH 8).
The same buffer was degassed and used to make the p-mercaptoethanol solution (2.5 M).
The p-mercaptoethanol was added with a gas-tight syringe and a spectrum was acquired
every minute and five minutes after an addition. Essentially no change is observed in the
family of spectra (Figure 5). The lack of change in the spectral properties of H39VIH63C
with the addition of p-mercaptoethanol indicates that the heme pocket may no longer be
accessible to small molecules. If p-mercaptoethanol was able to access the heme pocket,
it could not replace either of the heme axial ligands.
Addition of OTT. Considering the effect of OTT on the H63C variant (Chapter
IV Figure 9), OTT was titrated into a solution containing H39V/H63C in the same
method as p-mercaptoethanol (see above). The spectral effects of OTT on the
H39VIH63C variant (Figure 5) were more apparent than those of p-mercaptoethanol,
however, the only change was an overall decrease in intensity of the entire spectrum
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(300-800 nm). Again, this suggests that the mutations have produced a protein who e
heme pocket is inaccessible. Moreover, the two axial ligands cannot be replaced.
Ferrous H39VIH63C
UV-vis characteristics. Reduction of the H39V/H63C variant was achieved by
addition of dithionite. The UV-vis properties are shown in Figure 6. Interestingly,
ferrous H39VIH63 C has nearly identical spectral properties as ferrous H63C. The
similarities suggest that 1m is retained as a ligand in ferrous H39VIH63C.
The Fe(II)-CO of H39V/H63C. When CO is bubbled into a solution containing
ferrous H39V/H63C, the spectrum again shows similarities to the ferrous CO complex of
the H63C and H39C variant (Figure 7). The sharp and intense Soret peak at 418 nm and
the similar intensities of the a and ~ bands suggest an Im-Fe(II)-CO heme coordination
environment.
Axial ligand mutations (H39V IH63C) failed to produce a protein that exhibited
the unique spectral properties of ferrous CO P-450CAM . Reported axial mutations of Mb
[1, 4] have also failed to produce a thiolate-bound ferrous CO heme environment.
Consequently, axial mutations alone do not appear sufficient to stabilize thiolate ligation
to a ferrous CO heme.
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CHAPTER VI
SUMMARY AND CONCLUSIONS
All three variants exhibited thiolate ligation to the heme iron in the ferric
oxidation state. The ligation is corroborated by unique peaks in the UV-vis spectra (360
run and 750 nm) and by EPR spectroscopy and mass spectrometry in the H63C variant.
Cytochromes P-4S0 and P-420 (substrate-free) exhibit similar spectra to the mutants as
well. Furthermore, the H39C and H63C mutants exhibit a spin-state change
corresponding to the loss of the thiolate ligand likely due to weak ligation. thus the
thiolate is easily oxidized. The ferrous form of the H39C mutant clearly shows 10 of a
ligand upon reduction, likely Cys39. [n contrast, the spectrum of the ferrous form of the
H63C variant reveals a low-spin protein, consistent with retention of the thiolate as a
ligand and the native histidine as the second axial ligand. Cytochrome P-420 shows a
similar spectrum in the ferrous oxidation state, hence it is likely that upon reduction or p-
420 the thiolate is retained. Mo t researchers claim that the thiolate ligand is 10 t upon
reduction of P-420 (see references within). Addition of carbon monoxide (CO) 10 the
ferrous mutants shows spectra that are clearly histidine-CO ligated with Soret absorption
at 418 nm. These spectra are also similar to ferrous-CO P-420.
V/hile the ferric forms of the mutants show similarities with both PASO and P-
420, the ferrous forms show similarity to only P-420. The mutants are therefore
amenable to further probing the axial ligation of P-420, which is still in dispute. In
conclusion, the mutants H39C, H63C, and H39V/H63C of OM cyt bs are likely models
for axial ligation of cytochrome P-4S0 and P-420.
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APPENDIX
PROTOCOLS USED IN MUTAGENESIS
Phosphorylation of Oligonucleotides
Add: sufficient volume of TE buffer to oligonucleotide for a final concentration of 1.0
J.lg//lL solution.
Mix: 1.0 III dissolved primer (l J.lgIIlL)
4.0 ~ll Forward Kinase buffer" (5x)
1.0 ilL T4 Kinase"
1.0 ~lL ATpb
12.0 ilL dH20
Incubate: 60 min at 37°C
Heat: 10 min at 65°C to stop reaction
a Included in Transformer Site-Directed Mutagenesis kit (Clontech). b ATP = adenosine
triphosphate.
Purification of D A from E. coli cellsa
Transfer: 3 mL of overnight culture to two 1.5 mL microcentrifuge tubes
Centrifuge: 1-2 min at top speed (14,000 x g), pour off supernatant and blot on paper
towel
Mix: 200 ilL Cell Resuspension Solutionb to one tube then transfer entire cont nts to
second tube and completely resu pend cells
200 ilL Cell Lysis Solutionb and mix by inverting until solution is clear
200 ~Ll eutralization Solutionb and mix by inverting
Centrifuge: 5-10 min at top speed or until pellet i formed
Transfer: supernatant to sterile 5 cc syringe barrel with Miniprep olumnb attached
Add: 1 roL Minipreps D A Purification Resinb (resin should be mixed for I min prior to
addition)
Slowlv.· push sluITY through Miniprep Column
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Add: 2 mL Colunm Wash Solutionb to barrel and push through Miniprep Column
Centrifuge: Miniprep Column for 2 min at top speed to dry resin
Add: 50 ~L ofTE buffer preheated to 70°C and allow to react for I min
Centrifuge: 20 sec to elute DNA
a Modified from Wizard Plus Minipreps D A Purification System (Promega). b Included
in the Wizard Plus Miniprep DNA Purification System kit (Promega).
Typical digestion of DNA with restriction enzymes
Mix. 1.0 flL DNA
1.0 ilL buffer<l
I.U flL enzyme (0.5 ~lL of each enzyme if performing a double digestion)
7.0 ilL dH20
Incubate: 1 hr at 37°C
a Included with enzyme
Gel electrophoresis using agarose
Preparation of 1% agarose gel:
Mix.' 1 g of agarose
100 mL TAE buffer
Use a large Erlenmeyer flask covered with plastic wrap with holes. Heat the mixture by
microwave in short time intervals so boiling does not occur. Once all the agarose has
dissolved, add 200 ~lL of ethidium bromide and allow to cool slightly before pouring inLo
gel casting chamber. Pour slowly to avoid air bubbles, check for leaks, and insert comb
for wells. Allow gel to form for I hour.
Preparation of DNA for gel electrophoresis:
Mix: 10 flL previously digested DNA solution
2.0 flL dye
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Preparation of Marker:
Mix: 2.0 ~L D A (l Kb Ladder)
2.0 ~L dye
8.0 ~L dH20
Cover firm gel with additional TAE buffer. Inject DNA mixture into well . Refer to
apparatus manual for proper operation.
Isolation of DNA from gel electrophoresis
Method I-Adapted from GE ECLEAN II kit (BIO IOL)
Cut: desired bands from gel and weigh in pre-weighed tubes
Mix: 3 volumes ofNaI solution3
Incubate: 7 min at 55°C with mixing every 2 min to ensure that all agaro e dissolves
Add: 5 ~L of GLASSMILKa (vortex GLASSMILK for 1 min prior to addition)
Incubate: 7 min on ice with mixing every 2 min to ensure binding
Centrifuge: 5-15 sec at top speed and pour off supernatant
Resuspend pellet with 500 f.!L of ice-cold NEW wash 3
Centrifuge: 5-15 sec at top speed
Repeat: two more times
Resuspend: pellet with 20 ~L of dI-hO
Incubate: 4 min at 55°C and centrifuge for 30 sec at top speed to elute DNA
3 Included in GENECLEAN II kit (B10 10 I).
Method 2-Freeze squeeze with PhenollCHCl3 extraction and EtOH precipitation
Freeze Squeeze
Cut: desired bands from gel and weigh in pre-weighed tubes
Freeze. overnight at -20°C or for 45 min at -75 °C
Thaw: 5 min at 37°C and slice gel pieces again
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Freeze: 5 min in liquid nitrogen
Thaw: 10 min at 37°C
Centrifuge: 10 min at 10,000 x g in a Millipore canister
Add: 50)...l.L of dH20 and centrifuge for 5 min at 10,000 x g
PhenollCHCh extraction
lvfix: 1 volume of Phenol (chi lled)
1 volume of CHC13
Centrifuge: 30 sec at top speed
Add: 1 volume ofCHCI3 to aqueous (top) phase
Centrifi./ge: 30 sec at top speed
Transfer: aqueous (top) phase to clean microcentrifuge tube
EtOH precipitation
To aqueous phase:
Mix: 1.8 to 2 volumes of ice-cold EtOH (100%)
3 M Sodium acetate buffer (filter sterilized) to a final concentration of 0.3 M
Freeze: 2 h at -20°C
Centrifuge: 30 min at top speed and pour off ethanol
Add: 700)...l.L EtOH (70%)
Centrifuge.· 15 min at top speed, pour off ethanol and allow pellet to dry
Resuspend: pellet with 20 )...I.L dH20
Preparation of competent E coli cells for transformation
Inoculate: 100 mL sterile LB with 1 mL overnight culture grown from single colony
Incubate: with shaking (220 rpm) at 37°C until 00600 reaches 0.5 (3-5 h)
Chill· 20 min on ice when OD600 reaches 0.5
Centrifuge: 10 min at 1200 x g to pellet cells
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Resuspend: cells in 10 mL of freshly prepared, ice-cold, filter sterile TS
Transformation of D A into competent E. coli cells
Mix: 0.5-10 J-lL of purified DNA (use minimal amount of DNA stock solution for
control experiments)
100-200 J-lL competent E. coli cells
Incubate: 20 min on ic~
Heat: 2 min at 42°C
Chill: 2 min on ice
Add: 400 J-lL sterile LB media
Incubate: 30 min at 37°C to build antibiotic resistance
Spread: 50-100 J-lL on sterile LB agar plates and incubate overnight at 37°C
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APPENDIX
REAGENTS USED IN MUTAGENESIS
LB Media (I L)
Mix: 109 tryptone
5 g yeast extract
10 g NaCI
1000 mL dH20
In a large Erlenmeyer tlask, combine solids then add the water and stir to dissolve the
solids. Adjust to a pH of7.0 with 5N NaOH. Sterilize by autoclaving for 20 min at 15
PS1.
LB agar media (250 mL)
Mix: 2.5 g tryptone
] .25 g yeast extract
2.5 g NaCI
250 mL dH20
In a 500-mL flask, combine solids then add the water and stir to dissolve the solids.
Adjust to a pH of7.0 with 5N NaOH.
Add: 3.75 g agar
Add a magnetic stir bar (if antibiotic is to be added later), cover Hask opening with foil
and sterilize by autoclaving for 20 min at 15 psi. Flask must be kept at 48°C until ready
to pour into sterile Petrie dishes.
Ampicillin 50 mg/mL (lOOOx)
Mix: 500 mg ampicillin powder
10 mL dH20
Sterilize by syringe filter and aliquot. Store at -20°C.
Tetracycline 5 mg/mL (lOOx)
Mix. 5 mg tetracycline powder
I mL ethanol
Stir well to dissolve powder and use immediately. Do not store solutions.
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ISS (Transformation and Storage Solution)
Mix: 8.5 mL LB media
1 g PEG (mw gOOO)
101 mg MgCh
500 ~L DMSO
Prepare in a sterile conicaJ tube. Stir well to dissolve solids. Sterilize by yringe filter
and keep on ice.
IE buffer
Mix: 78.8 mg Tris-HCI (10 mM)
18.61 mg EDTA free acid (1 mM)
50 mL dH20
Adjust to pH 7.5 and sterilize by autoc1aving for 20 min at 15 psi.
IBE buffer (5x)
J\1ix: 27.25 g Tris free base (450 mM)
13.90 g Boric acid (450 mM)
1.45 g EDTA free acid (10 mM)
500 mL dH20
Dilute stock solution with five volumes dH20 to use.
T AE buffer (5x)
Mix. 12.10 g Tris free base (400 mM)
2.85 mL Glacial acetic acid (400 mM)
146 mg EDTA free acid (l0 mM)
500 mL dH20
Adjust pH to 7.5-7.8. Dilute stock solution with five volumes dH20 to use.
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